
1. pathog glob health. 2013 sep;107(6):299-304. doi:
10.1179/204777213x13777615588180.

malaria tertiary health care facility central india special
reference severe vivax: implications malaria control.

jain v(1), agrawal a, singh n.

author information: 
(1)regional medical research centre tribals, icmr, nagpur road garha,
jabalpur, madhya pradesh, india.

plasmodium vivax recognized cause severe fatal infection in
many parts world. prospective observational study undertaken a
tertiary health setting understand spectrum disease burden and
associated complications due p. vivax malaria central india. malaria
clinic regional medical research centre tribals operational at
netaji subhash chandra bose medical college hospital, jabalpur central
india, fever cases cases history fever referred for
screening malaria parasite microscopy rapid diagnostic test kits.
confirmation cases done pcr targeting 18s ribosomal rna gene of
the parasite exclude mixed infection p. falciparum. severe vivax malaria 
was found 22 (11Â·1%) 198 vivax patients. cerebral malaria, seizures,
severe malaria anaemia, respiratory distress observed 32%
subjects. multi-organ dysfunction syndrome common (36%). mortality was
recorded two patients neurological sequelae also observed two
patients time discharge. first report central india
where p. vivax shown associated severe signs malaria.
severe vivax malaria relatively new clinical entity studies from
different parts world needed understand clinical spectrum and
burden p. vivax successful treatment, also designing 
developing effective malaria control measures.

doi: 10.1179/204777213x13777615588180 
pmcid: pmc4001609
pmid: 24188240  [indexed medline]

